InfuSystem Holdings, Inc. Share Price

Equities

INFU

US45685K1025

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
8.12 USD +6.70% Intraday chart for InfuSystem Holdings, Inc. -0.98% -22.96%
Sales 2024 * 135M 10.84B Sales 2025 * 148M 11.85B Capitalization 173M 13.82B
Net income 2024 * 3M 240M Net income 2025 * 9M 720M EV / Sales 2024 * 1.27 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.17 x
P/E ratio 2024 *
52.4 x
P/E ratio 2025 *
19.3 x
Employees 508
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.19%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.70%
1 week-0.98%
Current month-5.25%
1 month-7.73%
3 months-15.68%
6 months-17.31%
Current year-22.96%
More quotes
1 week
7.57
Extreme 7.57
8.38
1 month
7.57
Extreme 7.57
8.89
Current year
7.57
Extreme 7.57
10.58
1 year
7.57
Extreme 7.57
11.44
3 years
6.10
Extreme 6.1
23.15
5 years
4.15
Extreme 4.15
23.26
10 years
1.20
Extreme 1.2
23.26
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 31/12/03
President 47 31/12/09
Director of Finance/CFO 53 11/03/20
Members of the board TitleAgeSince
Director/Board Member 67 16/05/22
Director/Board Member 77 07/05/14
Chairman 58 06/09/16
More insiders
Date Price Change Volume
26/04/24 8.12 +6.70% 27,842
25/04/24 7.61 -3.30% 30,441
24/04/24 7.87 -1.75% 18,683
23/04/24 8.01 +3.49% 12,517
22/04/24 7.74 -5.61% 75,317

Delayed Quote Nyse, April 26, 2024 at 09:00 pm

More quotes
InfuSystem Holdings, Inc. is a health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.12 USD
Average target price
14.75 USD
Spread / Average Target
+81.65%
Consensus